kadrige

Kadrige Announces New Growth for 2011

bdelattre — Wed, 11 Apr 2012 12:11:04 +0000

PARIS, France – 11^th April 2012 - Kadrige (www.kadrige.com), the European leader in SaaS (Software-as-a-Service) e-detailing and e-conferencing solutions dedicated to the health care industry, today confirmed its strong market position by registering a growth of 44% for 2011. During the last fiscal year, Kadrige’s revenues represented 30% in France and 70% at the international level. In total, more than 10 new major contracts were won by Kadrige in 2011.

Kadrige’s internationalization of its business is a strategic element for the company and the continued growth illustrates its unique understanding of issues related to the Hybrid* model designed for the pharmaceutical and health care sales models. Kadrige solutions are particularly well established in several countries such as Belgium, Brazil, Canada, Finland, France, Germany, Hungary, Italy, Luxemburg, Poland, Russia, Spain, Switzerland, Turkey, UK and USA.

Olivier Cadou, Kadrige President and Chairman of the Board, said “the constant increase in sales confirms the relevance of Kadrige’s strategic choices. These good results follow strong growth achieved in 2010, despite

the financial crisis and we should start year 2012 with extremely promising results, particularly at the international level.”

During 2011, following its development strategy, Kadrige has consolidated its presence in its key markets. To achieve this, the editor has pursued an intense commercial policy and has significantly increased its investments in R&D to offer innovative solutions adapted to the professional needs in the pharmaceutical industry. In 2012, the launch of new products will greatly contribute to sustaining this growth.

About Kadrige

Kadrige is the European leader in SaaS (Software-as-a-Service) e-detailing and e-conferencing solutions. Its deep understanding of the complex requirements of the pharmaceutical industry professionals has enabled the development of high performance and innovative solutions. Kadrige offers software solutions intended for health care sales forces, which enable a smooth transition from a classical health care visit model towards a “hybrid” model which brings a much higher return on investment. With this hybrid model, Health Care Professionals smartly mix face-to-face promotions of their products to the health care professional, and remote live e-detailing visits by combining telephone and internet. Founded in 2002, Kadrige has more than 50 employees and several clients in France and around the world among which are ranked in the top 20 pharmaceutical company ratings.

For more information about Kadrige and its products and services, visit www.kadrige.com

Kadrige Press Contact : MyNtic-PR – contact@myntic-pr.com – TEL : 33 (6) 74 68 37 93

Kadrige Announces Strong Growth for the First Semester 2011

bdelattre — Tue, 22 Nov 2011 12:50:54 +0000

Paris, France – 22nd November, 2011 – Kadrige, www.kadrige.com, a leading provider of remote edetailing and multichannel communication solutions and services for health care professionals, today confirmed its solid position on the market and announced strong growth for the first semester of 2011. Of particular note is an acceleration of its growth at the international level with sales representing over 54%.

Specifically, six new major customers were acquired by Kadrige following its strategy of the internationalization of its offering initiated in 2010. Kadrige also confirms that it is currently deploying in Europe over 2,000 licenses of its remote detailing software for one of the largest pharmaceutical companies in the world.

Hubert Catanese, CEO of Kadrige, said “We are proud to announce yet another semester of high growth in the context of the current global economy as we know it. Our strong position on the hybrid* medical sales market is a true differentiator and enables us to respond to the overall demands of pharmaceutical industry professionals. Our new international network also explains the breakthrough of our Kadrige solutions in all countries. We will continue to massively deploy and innovate to support our customers in their daily challenges.”

Kadrige solutions are particularly well established in various countries such as the United Kingdom, Germany, Spain, Russia, Turkey, Belgium and the United States. Since the beginning of 2011, Kadrige is now strongly present in Italy and most recently in Brazil and Canada.

About Kadrige

Kadrige is the European leader in SaaS (Software-as-a-Service) e-detailing and e-conferencing solutions. Its deep understanding of the complex requirements of the pharmaceutical industry professionals has enabled the development of high performance and innovative solutions and services. Kadrige offers software solutions intended for health care sales forces, which enable a smooth transition from a classical health care visit model towards a “hybrid” model which brings a much higher return on investment. With this hybrid* model, Health Care Professionals smartly mix face-to-face promotions of their products to the health care professional, and remote live e-detailing visits by combining telephone and internet. Founded in 2002, Kadrige has more than 50 employees and several clients in France and around the world among which are ranked in the top 20. For more information, please visit: www.kadrige.com

Kadrige Appoints Karen Zbyszinski, Vice President of Sales for the Americas

bdelattre — Mon, 17 Oct 2011 08:28:26 +0000

Seasoned Industry Executive to Lead Kadrige’s Development in USA

PARIS, France – October 17, 2011, Kadrige (www.kadrige.com), the European leader in SaaS (Software-as-a-Service) e-detailing and e-conferencing solutions dedicated to the health care industry, today announced the appointment of Karen Zbyszinski as Vice President of Sales for the Americas. Karen Zbyszinski will be responsible for defining Kadrige’s strategy and developing the company’s business in the US. She will lead the Kadrige US organization, focusing on major accounts and strategic partnerships in the territory.

Karen Zbyszinski is a seasoned executive bringing over 10 years of experience in the Hi Tech and Pharmaceutical industries. Prior to Kadrige, Karen held senior roles at InfoLogix, Exploria, and most recently was Director of CRM sales at Cegedim.

“Karen’s deep background in the software industry, combined with her experience in selling to the world’s major pharmaceutical companies makes her an excellent fit for Kadrige,” said Hubert Catanese, Chief Executive Officer, Kadrige. “Karen will bring to the company her deep understanding of the American pharmaceutical market and will allow Kadrige to become the number one supplier of remote e-detailing solutions through the Hybrid* sales model in the North American market.

“I am thrilled to lead the Kadrige team in the US and drive the adoption of e-detailing solutions that empower health care sales professionals,” said Karen Zbyszinski. “As evidenced by the company’s success all over the globe, customers of all sizes in the life sciences industry are seeking highly competitive integrated sales tools that reduce cost, increase productivity and bring new dimensions in flexibility. I believe Kadrige’s assets, its technology, its market expertise and its know-how enabling successful long term deployments, position the company in a very unique spot to be successful in the North American markets.”

Karen Zbyszinski is a Delaware Valley College, Doylestown, Cum Laude graduate and holds a Bachelor of Arts in English Language Studies gained in May 1998.

About Kadrige

Kadrige is the European leader in SaaS (Software-as-a-Service) e-detailing and e-conferencing solutions. Its deep understanding of the complex requirements of the pharmaceutical industry professionals has enabled the development of high performance and innovative solutions and services. Kadrige offers software solutions intended for health care sales forces, which enable a smooth transition from a classical health care visit model towards a “hybrid” model, which brings a much higher return on investment. With this hybrid* model, Health Care Professionals smartly mix face-to-face promotions of their products to the health care professional, and remote live e-detailing visits by combining telephone and internet. Founded in 2002, Kadrige has more than 50 employees and several clients in France and around the world among which are ranked in the top 20 pharmaceutical company ratings. For more information, please visit: www.kadrige.com.

Kadrige Appoints Hugues Jarreault as Finance Director

bdelattre — Tue, 27 Sep 2011 07:00:42 +0000

Paris, France 27th September 2011 – www.kadrige.com – Kadrige reinforces its management team with the appointment of Huguest Jarreault as Finance Director.

With ten years of professional experience, Hugues has multi-sectoral expertise in management, strategy and finance and will play a leading role at Kadrige in the development of its financial strategy. In addition, he will drive the administrative, accounting, tax and legal operations, reporting directly to senior management, and will be a member of the Kadrige Executive Committee.

Hughes holds a DECF Finance diploma from ACE Paris. Prior to joining Kadrige, Jarreault held various positions at SBP Audit & Expertise, Strictly Senso, Van Der Moolen, BPS Expertise and most recently at Caterpillar Finance France as accounting manager.

Hubert Catanese, Managing Director at Kadrige said: “Hugues JARREAULT is an essential part of our team. Versed in complex financial issues, he will support the company in its development and will enable Kadrige to develop a long-term financial strategy, adapted to our rapid growth and its associated objectives. His ability to support Kadrige in the internationalization of its activities is an important factor that has helped integrate Hugues JARREAULT into our executive committee. ”

About Kadrige

Kadrige is the European leader in SaaS (Software-as-a-Service) e-detailing and e-conferencing solutions. Its deep understanding of the complex requirements of the pharmaceutical industry professionals has enabled the development of high performance and innovative solutions and services. Kadrige offers software solutions intended for health care sales forces, which enable a smooth transition from a classical health care visit model towards a “hybrid” model, which brings a much higher return on investment. With this hybrid* model, Health Care Professionals smartly mix face-to-face promotions of their products to the health care professional, and remote live e-detailing visits by combining telephone and internet. Founded in 2002, Kadrige has more than 50 employees and several clients in France and around the world among which are ranked in the top 20 pharmaceutical company ratings.
For more information, please visit: www.kadrige.com.

Press contact, Kadrige: Franck Tupinier, Tel: +33 6 74 68 37 93. Email : ftupinier@myntic-pr.com

Kadrige Opens Subsidiary in USA

bdelattre — Mon, 11 Jul 2011 11:34:19 +0000

Paris, France – 12th July 2011 – Kadrige (www.kadrige.com), the market leader in e-detailing and multichannel sales solutions for the pharmaceutical and healthcare industries, today announced the opening of its subsidiary in the USA. By setting up office in Parsippany, New Jersey, Kadrige is accelerating its international development plan for the North American region.

The opening of a Kadrige subsidiary in United States was a natural move for the company since:

- North America is the leading global pharmaceutical market.
- New Jersey hosts the headquarters of several pharmaceutical companies, some of which are already Kadrige customers.
- Kadrige has already won several major contracts with leading North American groups who have chosen to rely on Kadrige medical hybrid calls to expand their market share.

The creation of a local team in the United States will enable Kadrige to complete ongoing projects, develop its business activity locally and provide quality support to its U.S. partners, the major one being Quintiles.

For this, the Kadrige USA subsidiary will rely on a team of complementary staff including business expert consultants, sales, project managers and IT engineers, most of which are of American nationality. Kadrige USA will market the full range of Kadrige solutions and services to enable the pharmaceutical industry professionals to benefit from next generation medical call solutions which will allow them to respond pragmatically to their needs: flexible promotional models proposed, improved productivity, increased impact and return on investment.

Hubert Catanese, Managing Director at Kadrige, said: “With its unique offer on the market, Kadrige gives U.S. companies access to solutions such as the medical hybrid call, which is widely recognized for its performance. Our new subsidiary brings our local customers the strength of a world-class player. Kadrige’s knowledge of the U.S. market and the synergy with our strategic partner Quintiles are also strong differentiators that will enable us to distinguish ourselves. ”

About Kadrige

Kadrige is the European leader in SaaS (Software-as-a-Service) e-detailing and e-conferencing solutions. Its deep understanding of the complex requirements of the pharmaceutical industry professionals has enabled the development of high performance and innovative solutions and services. Kadrige offers software solutions intended for health care sales forces, which enable a smooth transition from a classical health care visit model towards a “hybrid” model, which brings a much higher return on investment. With this hybrid* model, Health Care Professionals smartly mix face-to-face promotions of their products to the health care professional, and remote live e-detailing visits by combining telephone and internet. Founded in 2002, Kadrige has more than 50 employees and several clients in France and around the world among which are ranked in the top 20 pharmaceutical company ratings. For more information, please visit: www.kadrige.com.

Press contact, Kadrige: Franck Tupinier, Tel: +33 6 74 68 37 93. Email: ftupinier@myntic-pr.com

Kadrige announces the creation of its Advisory Board and appoints Xavier Rutyna as its first member

bdelattre — Mon, 27 Jun 2011 17:35:15 +0000

Paris, France – 27th June, 2011 – Kadrige (www.kadrige.com), the market leader in e-detailing and multichannel sales solutions for the pharmaceutical and healthcare industries, today announced the appointment of Xavier Rutyna as the first member of its newly created Advisory Board.

The Advisory Board, chaired by Olivier Cadou, Founder and Chairman of Kadrige, advises the Board of Directors about the strategic policy options and, in particular, about strategic developments in the areas where the company operates. The Advisory Board also advises the Board about the five-year plan which the Executive Committee submits every year, concerning strategic matters such as acquisitions, disinvestments, strategic partnerships, and the execution and follow-up of such issues. In principle, the Advisory Board meets every three months and more if required. The Committee was established through a decision of the Board of Directors in 2011, and will be comprised of 5 members.

Xavier’s has 25 years experience in the healthcare and software industries. He managed the CRM Business Development for Public Sector, Healthcare & Life Sciences for EMEA at Oracle Corporation. In this role, Xavier directed the business development strategy for these sectors. Prior to joining Oracle, he was Director of Life Sciences Product Marketing Europe for Siebel Inc. responsible for strategy, marketing and consulting to the pharmaceutical and medical devices industries. Before joining Siebel, Xavier held a number of sales and marketing management roles at Dendrite Inc. and at Cegedim. In addition, Xavier also had sales and management responsibilities at Marion Merrell Dow (Pharmaceutical company acquired by Sanofi).

Xavier is a well-established speaker and has delivered numerous presentations on customer relationship strategies within the pharmaceutical and healthcare ecosystems.

“I am honored to be the first member of Kadrige’s Advisory Board and will actively support Olivier Cadou to expand the company with other healthcare experts,” said Xavier Rutyna. “Kadrige successes in Europe with leading pharmaceutical companies, and its rapid international development are proving the accuracy of its hybrid rep vision, and the effectiveness of its multichannel sales model. Kadrige is the first company to implement (or introduce) efficient and qualitative remote customer interactions, with deep business intelligence knowledge and related metrics, from more than 10 years of experience in this area. I have no doubt that Kadrige has all the necessary expertise and means to rapidly become the world-class leading player in this area.” he added.

Olivier Cadou, President and Founder of Kadrige, said “The creation of an advisory board will enable Kadrige to expand its vision and improve its understanding of a rapidly changing international market, at the crossroads of the pharmaceutical and information technology world. This advisory board will include a framework for developing strategique initiatives and development priorities. I am delighted that Xavier Rutyna has joined this team. His experience and deep knowledge of international market and key players in the pharmaceutical industry, combined with his sense of innovation, will allow us to move faster in the right direction.”

About Kadrige

Kadrige is the European leader in SaaS (Software-as-a-Service) e-detailing and e-conferencing solutions. Its deep understanding of the complex requirements of the pharmaceutical industry professionals has enabled the development of high performance and innovative solutions and services. Kadrige offers software solutions intended for health care sales forces, which enable a smooth transition from a classical health care visit model towards a “hybrid” model, which brings a much higher return on investment. With this hybrid* model, Health Care Professionals smartly mix face-to-face promotions of their products to the health care professional, and remote live e-detailing visits by combining telephone and internet. Founded in 2002, Kadrige has more than 50 employees and several clients in France and around the world among which are ranked in the top 20 pharmaceutical company ratings.

For more information, please visit: www.kadrige.com.
Press contact, Kadrige: Franck Tupinier, Tel: +33 6 74 68 37 93. Email : ftupinier@myntic-pr.com

Kadrige announces the creation of its Advisory Board and appoints Xavier Rutyna as its first member

bdelattre — Mon, 27 Jun 2011 13:46:51 +0000

Paris, France – 27th June, 2011 – Kadrige (www.kadrige.com), the market leader in e-detailing and multichannel sales solutions for the pharmaceutical and healthcare industries, today announced the appointment of Xavier Rutyna as the first member of its newly created Advisory Board.

The Advisory Board, chaired by Olivier Cadou, Founder and Chairman of Kadrige, advises the Board of Directors about the strategic policy options and, in particular, about strategic developments in the areas where the company operates. The Advisory Board also advises the Board about the five-year plan which the Executive Committee submits every year, concerning strategic matters such as acquisitions, disinvestments, strategic partnerships, and the execution and follow-up of such issues. In principle, the Advisory Board meets every three months and more if required. The Committee was established through a decision of the Board of Directors in 2011, and will be comprised of 5 members.

Xavier’s has 25 years experience in the healthcare and software industries. He managed the CRM Business Development for Public Sector, Healthcare & Life Sciences for EMEA at Oracle Corporation. In this role, Xavier directed the business development strategy for these sectors. Prior to joining Oracle, he was Director of Life Sciences Product Marketing Europe for Siebel Inc. responsible for strategy, marketing and consulting to the pharmaceutical and medical devices industries. Before joining Siebel, Xavier held a number of sales and marketing management roles at Dendrite Inc. and at Cegedim. In addition, Xavier also had sales and management responsibilities at Marion Merrell Dow (Pharmaceutical company acquired by Sanofi).

Xavier is a well-established speaker and has delivered numerous presentations on customer relationship strategies within the pharmaceutical and healthcare ecosystems.

“I am honored to be the first member of Kadrige’s Advisory Board and will actively support Olivier Cadou to expand the company with other healthcare experts,” said Xavier Rutyna. “Kadrige successes in Europe with leading pharmaceutical companies, and its rapid international development are proving the accuracy of its hybrid rep vision, and the effectiveness of its multichannel sales model. Kadrige is the first company to implement (or introduce) efficient and qualitative remote customer interactions, with deep business intelligence knowledge and related metrics, from more than 10 years of experience in this area. I have no doubt that Kadrige has all the necessary expertise and means to rapidly become the world-class leading player in this area.” he added.

Olivier Cadou, President and Founder of Kadrige, said “The creation of an advisory board will enable Kadrige to expand its vision and improve its understanding of a rapidly changing international market, at the crossroads of the pharmaceutical and information technology world. This advisory board will include a framework for developing strategique initiatives and development priorities. I am delighted that Xavier Rutyna has joined this team. His experience and deep knowledge of international market and key players in the pharmaceutical industry, combined with his sense of innovation, will allow us to move faster in the right direction.”

About Kadrige

Kadrige is the European leader in SaaS (Software-as-a-Service) e-detailing and e-conferencing solutions. Its deep understanding of the complex requirements of the pharmaceutical industry professionals has enabled the development of high performance and innovative solutions and services. Kadrige offers software solutions intended for health care sales forces, which enable a smooth transition from a classical health care visit model towards a “hybrid” model, which brings a much higher return on investment. With this hybrid* model, Health Care Professionals smartly mix face-to-face promotions of their products to the health care professional, and remote live e-detailing visits by combining telephone and internet. Founded in 2002, Kadrige has more than 50 employees and several clients in France and around the world among which are ranked in the top 20 pharmaceutical company ratings.

For more information, please visit: www.kadrige.com.
Press contact, Kadrige: Franck Tupinier, Tel: +33 6 74 68 37 93. Email : ftupinier@myntic-pr.com

Kadrige raises 3.3 M€ to finance its development

bdelattre — Tue, 26 Apr 2011 08:00:52 +0000

Paris, France – 26^th April, 2011 – Kadrige, www.kadrige.com, a leading provider of remote edetailing and multichannel communication solutions and services for health care professionals, today announced that it has secured a new round of funding from Amundi Private Equity Funds (Amundi PEF) and from its existing investors (CM-CIC, Matignon Investissement & Gestion and H2i). For this operation, Kadrige was accompanied and advised by Aelios Finance.

This new injection of capital (3.3 million Euros) endorses Kadrige’s performance and aims to support the internationalization strategy of its offering. Kadrige also intends to reinforce its R&D investments and expand its sales teams in order to accelerate the development of its market share in the pharmaceutical industry. Finally, this funding will help Kadrige extend its customer services offering, especially for its installed base which is rapidly growing with a strong extension internationally.

Kadrige develops software solutions which enable health care manufacturers to evolve from their traditional medical call model towards a « hybrid* » call model. Today, Kadrige equips multiple customers including the leading worldwide pharmaceutical companies. In 2010, Kadrige achieved more than 56% of its turnover from exports and concluded strategic alliances with leading partners such as Quintiles, USA.

Béatrice Llirbat, Partner at Amundi PEF said « We are delighted to enter into the capital of a French enterprise with high exports and a very bright future for the years to come. We strongly believe in the profound evolution of the Pharmaceutical Industry’s promotional models and Kadrige has become the flagship of this change with proven, appreciated, solutions and a solid team. Our investment in Kadrige reflects Amundi’s desire to help young ambitious French companies who wish to make a difference in changing markets.»

Olivier CADOU, Founder and President of Kadrige, added: “this new round of funding is a double recognition on the part of our investors. It rewards our performance and demonstrates their confidence in Kadrige’s potential for development. Now, our objective is a strong and sustained growth to take a definitive global leadership position in the market.”

About Kadrige

Kadrige is the European leader in SaaS (Software-as-a-Service) e-detailing and e-conferencing solutions. Its deep understanding of the complex requirements of the pharmaceutical industry professionals has enabled the development of high performance and innovative solutions and services. Kadrige offers software solutions intended for health care sales forces, which enable a smooth transition from a classical health care visit model towards a “hybrid” model which brings a much higher return on investment. With this hybrid* model, Health Care Professionals smartly mix face-to-face promotions of their products to the health care professional, and remote live e-detailing visits by combining telephone and internet. Founded in 2002, Kadrige has more than 50 employees and several clients in France and around the world among which are ranked in the top 20 pharmaceutical company ratings.

For more information, please visit: www.kadrige.com.

Press contact, Kadrige: Franck Tupinier, Tel: +33 6 74 68 37 93. Email : ftupinier@myntic-pr.com

About Amundi Private Equity Funds (Amundi PEF)

With assets under management of €4.1 billion at 31 December 2010, Amundi Private Equity Funds offers its retail and institutional clients an extensive range of products tailored to their needs and giving them access to private equity and infrastructure funds of funds as well as private equity funds dedicated to direct shareholdings in non-listed companies. With over 60 investment professionals based in Paris, Bucharest, Casablanca, Tunis and Warsaw, Amundi PEF helps companies at every stage of their growth, from creation to transmission, and forms long-standing and trusting relationships with its clients. Amundi PEF is an expertise of the Amundi Group. www.amundi-pef.comPress contact: Sonia Kobiela – Tel. 01.76.33.79.56 – E-mail : sonia.kobiela@amundi.com

AboutAelios Finance

Aelios Finance is a Consulting firm specializing in the support of entrepreneurs in the overall operations of the financial life of their business, Aelios Finance has experience of over 180 transactions and is the French member of the world's largest network of mergers & acquisitions, M & A International Inc. www.aeliosfinance.com, www.mergers.net

Kadrige Announces Record Revenues for 2010

bdelattre — Wed, 02 Feb 2011 18:16:35 +0000

Kadrige, the European leader in SaaS (Software-as-a-Service) e-detailing and e-conferencing solutions and services dedicated to the health care industry, today confirmed its strong market position by registering a record growth of 89% of its turnover in 2010.

This significant growth is the result of the Company’s strategic development throughout 2010, the launch of new products, the signature of major partnerships and the continued development of international sales (more than 56% of turnover was generated outside of France).

During 2010, 10 new contracts were signed with major global pharmaceutical companies among which one with a major player in the USA which represents the best reference deal signed by Kadrige on this market

This evolution illustrates the innovative nature of Kadrige’s solutions and its unique knowledge of the pharmaceutical sales models. Kadrige’s “Hybrid” solutions are particularly well established in various countries such as UK, Germany, Spain, Russia, Turkey, Poland, Belgium, Luxemburg and the USA.

Kadrige also refined its business strategy and signed agreements with complementary alliance partners. Among these, an exclusive agreement was signed with Quintiles to enable pharmaceutical companies to access new development models that generate growth and improve productivity.

Olivier Cadou, Founder and President of Kadrige, said: “Following 8 consecutive quarters of record sales, Kadrige is poised to continue its momentum; all pharmaceutical companies now know that they must implement e-detailing solutions. Kadrige is today the company that has the best references in the industry. 2011 will see a very strong acceleration of deployments of our solutions across the globe. Investments in recent years have paid off and the new investment committed in this new year will enable Kadrige to move from a predominantly European player to a true global player.”

About Kadrige

Kadrige is the European leader in SaaS (Software-as-a-Service) e-detailing and e-conferencing solutions. Its deep understanding of the complex requirements of the pharmaceutical industry professionals has enabled the development of high performance and innovative solutions and services. Kadrige offers software solutions intended for health care sales forces, which enable a smooth transition from a classical health care visit model towards a “hybrid” model which brings a much higher return on investment. With this hybrid model, Health Care Professionals smartly mix face-to-face promotions of their products to the health care professional, and remote live e-detailing visits by combining telephone and internet. Founded in 2002, Kadrige has more than 50 employees and several clients in France and around the world among which are ranked in the top 20 pharmaceutical company ratings. For more information, please visit www.kadrige.com

Kadrige

Press Contact : MyNtic-PR – contact@myntic-pr.com - TEL: 33 (6) 74 68 37 93

Quintiles and Kadrige Partner to Improve Commercialization of Pharmaceutical Brands

bdelattre — Tue, 16 Nov 2010 09:00:47 +0000

Market leaders integrate expertise and e-solutions in Europe and the US RESEARCH TRIANGLE PARK, N.C., and PARIS – November 16, 2010 – Quintiles, the world’s leading biopharmaceutical services company, and Kadrige, the market leader in e-detailing and multichannel sales solutions for the pharmaceutical and healthcare industries, today announced a global alliance that brings innovative models to physician detailing to help biotech and pharmaceutical companies increase productivity, overcome complexity and more efficiently demonstrate value for their therapies.

Through a co-promotion agreement covering Europe and the United States, Quintiles and Kadrige will enable biotech and pharma customers to reduce one of their largest fixed costs by transitioning from a traditional healthcare visit model to a “hybrid” model that blends face-to-face physician discussions with live, remote e-detailing calls via the telephone and internet. The co-promotion agreement also enables Quintiles and Kadrige to develop Web-Call centers, which allow medical sales representatives to train or call healthcare professionals on a full-time basis.

This alliance is the first of its kind in the industry. Kadrige and Quintiles’ joint offering provides the full continuum of services and solutions required to evolve smoothly from an aging promotional model to a new one, based on the smart mix of multiple channels of communication that will bring to the biotech or pharma company, cost reductions, sales impact increase and a much larger flexibility to react to market evolutions.

“With Kadrige, we can revolutionize the lifecycle implementation of a brand by customizing physician detailing in accordance with its lifecycle need,” said Michael Ackermann, Senior Vice President of Commercialization for Quintiles. “We are committed to helping our customers succeed in the New Health, and these innovative hybrid call center and multichannel models are the transformative solutions our customers require.”

“While many companies are piloting a hybrid approach, our agreement with Quintiles provides a real-world solution that saves customers time and money by delivering the right message at the right time to the right target through the right channel,” Kadrige Founder and Chairman Olivier Cadou said. “This agreement expands our presence in the U.S. and Europe through access to the largest biotech and pharma sales force in the world.”

About Quintiles

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries works with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies navigate risk and seize opportunities in an environment where change is constant. For more information, please visit www.quintiles.com.

About Kadrige

Kadrige is the European leader in SaaS (Software-as-a-Service) e-detailing and e-conferencing solutions. Its deep understanding of the complex requirements of pharmaceutical industry professionals has enabled the development of a range of high performance and innovative solutions and services. Kadrige offers software solutions intended for health care sales forces, as well as an ongoing support program, enabling a smooth transition from a classical health care visit model toward a “hybrid” model which brings a much higher return on investment. With this hybrid model, medical sales representatives can smartly blend face-to-face promotions of their products to health care professionals, and remote live e-detailing visits by combining telephone and internet. Founded in 2002, Kadrige has near to 60 employees and several clients in 15 countries which are ranked in the top 20 pharmaceutical company ratings. For more information, please visit www.kadrige.com.

Forward-Looking Statements

This press release contains “forward-looking statements,” based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from expectations and projections. Risks and uncertainties include, among other things, general industry conditions; technological advances and patents attained by competitors; challenges inherent in the research and development and regulatory processes; challenges related to product marketing, such as the unpredictability of market acceptance for new products; inconsistency of treatment results among patients; the potential for product failures; potential difficulties in manufacturing; governmental laws and regulations affecting domestic and foreign operations and the ongoing success of the collaboration. The parties expressly disclaim any intent or obligation to update these forward-looking statements except as required to do so by law.